Updated Jul 16, 2026
Kapadia Sandip has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.68M.
Sandip Kapadia is an executive known for his role in the biotechnology sector, particularly with Harmony Biosciences Holdings, Inc. He has been involved in various capacities that leverage his expertise in finance and operations within the pharmaceutical industry.
| Role | Insider |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-29 | HRMY | Harmony Biosciences Holdings, Inc. | S — Open-market sale [10b5-1] | 3.7K | $37.15 | $139K |
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | F — Tax withholding / forfeiture | 2.6K | $36.82 | $94K |
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | M — Option exercise | 4.7K | $0.00 | |
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | F — Tax withholding / forfeiture | 2.2K | $36.82 | $82K |
| 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | M — Option exercise | 3.8K | $0.00 | |
| 2026-01-21 | HRMY | Harmony Biosciences Holdings, Inc. | S — Open-market sale [10b5-1] | 21.0K | $35.92 | $753K |
| 2025-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | F — Tax withholding / forfeiture | 24.0K | $27.56 | $663K |
| 2025-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | M — Option exercise | 45.0K | $0.00 | |
| 2025-08-15 | HRMY | Harmony Biosciences Holdings, Inc. | S — Open-market sale | 21.6K | $36.50 | $787K |
| 2024-10-02 | HRMY | Harmony Biosciences Holdings, Inc. | F — Tax withholding / forfeiture | 32.1K | $40.00 | $1.28M |
| 2024-10-02 | HRMY | Harmony Biosciences Holdings, Inc. | M — Option exercise | 60.0K | $0.00 |
Sandip Kapadia is an executive known for his role in the biotechnology sector, particularly with Harmony Biosciences Holdings, Inc. He has been involved in various capacities that leverage his expertise in finance and operations within the pharmaceutical industry.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.68M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kapadia Sandip profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.